From: Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
Parameter | Pegylated interferon α 2b (PEG-INTRON) (n=25) | Pegylated interferon α 2a (PEGASYS) (n=19) | P-value | |||
---|---|---|---|---|---|---|
Non-responders (n=6) | Responders (n=19) | Non-responders (n=9) | Responders (n=10) | |||
CXCL5(pg/ml) | Pretreatment | 1.27500 ± .969563 | 1.33774 ± .792903 | 1.22044 ± 1.022862 | 1.42330 ± .925645 | 0.000a, 0.602b, 0.875c, 0.770d, 0.345e, 0.703f |
12 Weeks | .71167 ± .459045 | .90895 ± .588673 | 1.00456 ± .699765 | .80800 ± .609552 | ||
24 Weeks | .7220 ± .46685 | .9518 ± .57106 | .7664 ± .43326 | .8625 ± .63422 | ||
CXCL9(pg/ml) | Pretreatment | .19233 ± .114175 | .20568 ± .076974 | .18922 ± .074028 | .18810 ± .063218 | 0.082a, 0.744b, 0.415c, 0.962d, 0.199e, 0.517f |
12 Weeks | .19233 ± .124331 | .14284 ± .040243 | .16744 ± .127693 | .12573 ± .053301 | ||
24 Weeks | .13750 ± .072116 | .18945 ± .121548 | .15544 ± .097306 | .13464 ± .055773 | ||
CXCL11(pg/ml) | Pretreatment | .13520 ± .080444 | .13945 ± .072608 | .17885 ± .093798 | .15742 ± .100730 | 0.187a, 0.584b, 0.459c, 0.435d, 0.065e, 0.634f |
12 Weeks | .15260 ± .081185 | .16190 ± .098519 | .17154 ± .049891 | .19991 ± .152004 | ||
24 Weeks | .14883 ± .038071 | .17705 ± .102551 | .12744 ± .044230 | .19255 ± .161593 | ||
CXCL12(pg/ml) | Pretreatment | 84.69483 ± 206.396544 | .39289 ± .154332 | .55400 ± .244147 | .45300 ± .163781 | 0.117a, 0.085b, 0.085c, 0.229d, 0.065e, 0.085f |
12 Weeks | .49400 ± .065023 | .42263 ± .147961 | .54833 ± .196068 | .43490 ± .205439 | ||
24 Weeks | .373 ± .1015 | .439 ± .1431 | .496 ± .1217 | .42900 ± .1590 | ||
CXCL13(pg/ml) | Pretreatment | .34000 ± .069974 | .31553 ± .105584 | .40567 ± .274538 | .29844 ± .105315 | 0.002a, 0.085b, 0.085c, 0.229d, 0.065e, 0.085f |
12 Weeks | .50483 ± .139194 | .43342 ± .246432 | .52944 ± .271026 | .34133 ± .145816 | ||
24 Weeks | .47333 ± .181595 | .53990 ± .377348 | .62800 ± .455588 | .39955 ± .128076 | ||
CXCL16(ng/ml) | Pretreatment | .94633 ± .101567 | .87458 ± .244527 | 1.14611 ± .424545 | 1.01250 ± .331579 | 0.000a, 0.221b, 0.527c, 0.689d, 0.577e, 0.866f |
12 Weeks | 1.15333 ± .298719 | 1.11037 ± .323698 | 1.25411 ± .342009 | 1.24990 ± .417217 | ||
24 Weeks | 1.26867 ± .353015 | 1.13953 ± .408803 | 1.29189 ± .354069 | 1.28820 ± .402766 | ||
E-cadherin(ng/ml) | Pretreatment | .41983 ± .425530 | .40989 ± .436687 | .82833 ± .843119 | .68330 ± .660015 | 0.140a, 0.274b, 0.749c, 0.504d, 0.578e, 0.794f |
12 Weeks | .72350 ± .666040 | .55905 ± .577851 | .92678 ± .782186 | .74020 ± .657444 | ||
24 Weeks | .63783 ± .634553 | .77832 ± .858560 | .81578 ± .834449 | .81032 ± .779431 |